Prashant K.

EmendoBio develops next generation gene editing tools for genetic disorders, addressing the current technological gaps for realizing the promise of gene therapy.

• Pioneered strategic alliances and licensing agreements to position EmendoBio's gene editing technologies in global markets.
• Led cross-functional global initiatives to enhance EmendoBio's business development efforts and strategic acquisitions.
• Drove the expansion of EmendoBio's intellectual property portfolio through strategic M&A and licensing deals.

Generian discovers and develops small molecules that target previously undruggable targets to improve drug development options.

• Orchestrated and closed a $180 million transformational collaboration, enhancing Generian's market position and drug discovery capabilities.
• Spearheaded strategic partnerships and licensing opportunities to advance the company’s innovative drug discovery platform.
• Enhanced Generian's pipeline through targeted outlicensing and partnerships, focusing on difficult-to-drug protein targets.

Editas Medicine focuses on gene-editing technology to develop transformative genomic medicines for people living with serious diseases.

• Developed and implemented competitive intelligence strategies to maintain Editas' position in the competitive CRISPR space.
• Established infrastructure improvements, including CRMs and valuation models, to streamline business development processes.
• Led strategic collaborations to advance gene-edited cell therapy programs, particularly in ophthalmic and rare diseases.

AMAG Pharmaceuticals develops and delivers innovative medicines with a focus on underserved conditions in hematology, oncology, and women’s health.

• Led the execution of three transformational business transactions to expand AMAG's portfolio and market reach.
• Evaluated and pursued potential in-licensing opportunities and complementary product acquisitions.
• Played a pivotal role during AMAG's acquisition by COVIS Pharma, ensuring strategic alignment and business continuity.

Kaufman Hall provides financial and strategic advisory services, helping healthcare organizations achieve operational success and financial sustainability.

Stifel Financial Corp. offers wealth management and investment banking services, including mergers and acquisitions, underwriting, and capital raising.

Standard Chartered Bank provides banking and financial services to multinational corporations and institutional clients.

Lazard is a financial advisory and asset management firm specializing in mergers, acquisitions, and capital markets across various sectors.

Merrill Lynch provides wealth management, securities trading and sales, and corporate finance services globally.